The HCV serum proteome: a search for fibrosis protein markers.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 19226329)

Published in J Viral Hepat on February 15, 2009

Authors

K J Cheung1, K Tilleman, D Deforce, I Colle, H Van Vlierberghe

Author Affiliations

1: Department of Hepatology and Gastroenterology, Ghent University Hospital, Ghent, Belgium. kinjip.cheung@ugent.be

Articles citing this

A serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep (2013) 1.27

Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology (2014) 1.01

A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis. J Gastroenterol (2014) 0.95

Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. J Gastroenterol (2014) 0.93

Genomics and proteomics in liver fibrosis and cirrhosis. Fibrogenesis Tissue Repair (2012) 0.90

Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response. PLoS One (2015) 0.89

Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study. Hepat Mon (2013) 0.89

Protective effect of Phellinus linteus polysaccharide extracts against thioacetamide-induced liver fibrosis in rats: a proteomics analysis. Chin Med (2012) 0.88

Serpin induced antiviral activity of prostaglandin synthetase-2 against HIV-1 replication. PLoS One (2011) 0.86

Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers. Proteome Sci (2010) 0.84

Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma. J Gastroenterol (2015) 0.83

Passive immunization to reduce Campylobacter jejuni colonization and transmission in broiler chickens. Vet Res (2014) 0.81

Dengue-2 structural proteins associate with human proteins to produce a coagulation and innate immune response biased interactome. BMC Infect Dis (2011) 0.80

Human systems immunology: hypothesis-based modeling and unbiased data-driven approaches. Semin Immunol (2013) 0.80

Investigation of plasma biomarkers in HIV-1/HCV mono- and coinfected individuals by multiplex iTRAQ quantitative proteomics. OMICS (2011) 0.78

Serum Mac-2 binding protein is a novel biomarker for chronic pancreatitis. World J Gastroenterol (2016) 0.77

The identification of unique serum proteins of HIV-1 latently infected long-term non-progressor patients. AIDS Res Ther (2010) 0.77

Proteomics approaches to fibrotic disorders. Fibrogenesis Tissue Repair (2012) 0.77

Danoprevir monotherapy decreases inflammatory markers in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother (2011) 0.76

Immunization with the immunodominant Helicobacter suis urease subunit B induces partial protection against H. suis infection in a mouse model. Vet Res (2012) 0.76

iTRAQ-Based Proteomics Identification of Serum Biomarkers of Two Chronic Hepatitis B Subtypes Diagnosed by Traditional Chinese Medicine. Biomed Res Int (2016) 0.75

Proteomic profiling of HBV infected liver biopsies with different fibrotic stages. Proteome Sci (2017) 0.75

Articles by these authors

Pure laparoscopic full-left living donor hepatectomy for calculated small-for-size LDLT in adults: proof of concept. Am J Transplant (2013) 2.36

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23

Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat (2014) 1.68

Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat (2014) 1.67

Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57

Reduced amounts and abnormal forms of phospholipase C zeta (PLCzeta) in spermatozoa from infertile men. Hum Reprod (2009) 1.43

Gastric emptying of solids in cirrhotic and peritoneal dialysis patients: influence of peritoneal volume load. Eur J Gastroenterol Hepatol (2002) 1.41

CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. AJR Am J Roentgenol (2000) 1.22

Differential proteome analysis of normal and osteoarthritic chondrocytes reveals distortion of vimentin network in osteoarthritis. Osteoarthritis Cartilage (2007) 1.01

Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy. J Hepatol (1998) 1.00

Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides. Rheumatology (Oxford) (2008) 1.00

Value of MR cholangiography in the evaluation of postoperative biliary complications following orthotopic liver transplantation. Eur Radiol (2000) 0.93

Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis. Ann Rheum Dis (2007) 0.92

Proteome characterization of human articular chondrocytes leads to novel insights in the function of small heat-shock proteins in chondrocyte homeostasis. Osteoarthritis Cartilage (2009) 0.91

Radionuclide therapy for hepatocellular carcinoma. Acta Gastroenterol Belg (2011) 0.90

NKT cells: manipulable managers of joint inflammation. Rheumatology (Oxford) (2007) 0.90

Development and validation of an LC-MS/MS method for the simultaneous determination of deoxynivalenol, zearalenone, T-2-toxin and some masked metabolites in different cereals and cereal-derived food. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2012) 0.90

Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI. Abdom Imaging (2002) 0.88

Hepatic involvement in hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler Weber syndrome. Acta Gastroenterol Belg (2015) 0.88

Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection. J Med Virol (2013) 0.87

Altered expression of alpha E beta 7 integrin on intra-epithelial and lamina propria lymphocytes in patients with Crohn's disease. Acta Gastroenterol Belg (1998) 0.86

Deguelin inhibits expression of IkappaBalpha protein and induces apoptosis of B-CLL cells in vitro. Leukemia (2007) 0.86

X linked agammaglobulinaemia and rheumatoid arthritis. Ann Rheum Dis (2004) 0.86

Serum protein N-glycosylation in paediatric non-alcoholic fatty liver disease. Pediatr Obes (2012) 0.84

Hepatic veno-occlusive disease: MRI findings. Abdom Imaging (2002) 0.84

Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response. Aliment Pharmacol Ther (2004) 0.84

Differentiation of F4 receptor profiles in pigs based on their mucin 4 polymorphism, responsiveness to oral F4 immunization and in vitro binding of F4 to villi. Vet Immunol Immunopathol (2012) 0.84

The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth. Clin Transplant (2011) 0.81

Hepatitis E seroprevalence in east and west Flanders, Belgium. Acta Gastroenterol Belg (2012) 0.81

F4-related mutation and expression analysis of the aminopeptidase N gene in pigs. J Anim Sci (2014) 0.81

Immunizing pigs with Ascaris suum haemoglobin increases the inflammatory response in the liver but fails to induce a protective immunity. Parasite Immunol (2011) 0.80

Risk factors for hepatitis C: past, present and future. Acta Gastroenterol Belg (2002) 0.80

A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients. Acta Gastroenterol Belg (2010) 0.80

Progressive familial intrahepatic cholestasis and benign recurrent intrahepatic cholestasis: a review. Acta Gastroenterol Belg (2012) 0.80

Targeting aminopeptidase N, a newly identified receptor for F4ac fimbriae, enhances the intestinal mucosal immune response. Mucosal Immunol (2012) 0.80

Haemostasis monitoring during sequential aortic valve replacement and liver transplantation. Acta Gastroenterol Belg (2010) 0.80

Hepatitis C infection-related liver disease: patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults. Transplantation (2004) 0.79

The determination of cocaine, benzoylecgonine, and cocaethylene in small-volume oral fluid samples by liquid chromatography-quadrupole-time-of-flight mass spectrometry. J Anal Toxicol (2004) 0.79

Symptomatic liver injury probably related to sertraline. Gastroenterol Clin Biol (1998) 0.79

Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti-E1 envelope antibody titers. J Med Virol (2000) 0.79

The HepCar registry: report on a one-year registration program of hepatocellular carcinoma (HCC) in Belgium. What is daily practice in HCC? Acta Gastroenterol Belg (2006) 0.79

Capsule endoscopy findings in cirrhosis with portal hypertension: a prospective study. Dig Liver Dis (2008) 0.79

Proteomic study to identify factors in follicular fluid and/or serum involved in in vitro cumulus expansion of porcine oocytes. Soc Reprod Fertil Suppl (2009) 0.79

Weekly pegylated interferon alpha-2b vs daily interferon a-2b versus standard regimen of interferon a-2b in the treatment of patients with chronic hepatitis C virus infection. Acta Gastroenterol Belg (2009) 0.78

The management of patients with mild hepatitis C. Acta Gastroenterol Belg (2005) 0.78

Relapsing ascites and uremia due to urinary bladder leakage. Eur J Intern Med (2001) 0.78

Early arterial revascularization after hepatic artery thrombosis may avoid graft loss and improve outcomes in adult liver transplantation. Transplant Proc (2010) 0.78

Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial. J Viral Hepat (2003) 0.78

Hepatitis C-seroconversion within three to six months after having contracted clinical syphilis and/or lymphogranuloma venereum rectitis in five homosexually active, HIV seropositive men. Acta Clin Belg (2009) 0.78

Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust study. Acta Gastroenterol Belg (2010) 0.78

Impact of allelic dropout on evidential value of forensic DNA profiles using RMNE. Bioinformatics (2008) 0.77

One-sided limb lymphedema in a liver transplant recipient receiving sirolimus. Acta Gastroenterol Belg (2008) 0.77

Invasive infection with Rhodococcus equi--two case reports and review of literature. Acta Clin Belg (2010) 0.77

Hepatitis C virus: the burden of the disease. Acta Gastroenterol Belg (2002) 0.77

Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis. J Immunol Methods (2012) 0.77

Splenectomy and liver transplantation. Transplant Proc (2001) 0.77

Guidelines for the management of chronic hepatitis C in patients infected after substance use. Acta Gastroenterol Belg (2005) 0.77

Treatment of chronic hepatitis C in patients with human immunodeficiency virus (HIV) with weekly peginterferon alpha-2b plus ribavirin: a multi-centred Belgian study. Acta Gastroenterol Belg (2010) 0.77

Calciphylaxis: a rare complication in alcoholic liver disease. Acta Clin Belg (2013) 0.77

Previous intravenous substance use and outcome of liver transplantation in patients with chronic hepatitis C infection. Transplant Proc (2009) 0.77

Malignant focal hepatic lesions complicating underlying liver disease: dual-phase contrast-enhanced spiral CT sensitivity and specificity in orthotopic liver transplant patients. Eur Radiol (2001) 0.77

The Disease Burden of Hepatitis C in Belgium : An update of a realistic disease control strategy. Acta Gastroenterol Belg (2015) 0.76

Infected intracardiac thrombi: complication of vascular access in haemodialysis patients. Nephrol Dial Transplant (1995) 0.76

IgG4-related cholangitis: Case report and literature review. Acta Gastroenterol Belg (2015) 0.76

Analysis of melphalan adducts of 2'-deoxynucleotides in calf thymus DNA hydrolysates by capillary high-performance liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B Biomed Sci Appl (1999) 0.76

Induction of tolerance in solid organ transplantation: the rationale to develop clinical protocols in liver transplantation. Transplant Proc (2009) 0.76

Cutaneous infection by Alternaria infectoria in a liver transplant recipient: a case report. Acta Gastroenterol Belg (2014) 0.76

Quality of life assessment in radionuclide therapy: a feasibility study of the EORTC QLQ-C30 questionnaire in palliative (131)I-lipiodol therapy. Eur J Nucl Med Mol Imaging (2002) 0.76

The choice of recipient does not have a bearing on early outcome in liver transplant patients receiving grafts from non-heart-beating donors: a reappraisal? Transplant Proc (2007) 0.76

Current and future health and economic impact of hepatitis C in Belgium. Acta Gastroenterol Belg (2014) 0.76

Combining iodine-131 Lipiodol therapy with low-dose cisplatin as a radiosensitiser: preliminary results in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging (2002) 0.76

Living related adult-to-adult liver transplantation: which patient should benefit from this technique? Acta Gastroenterol Belg (2001) 0.75

Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients. Aliment Pharmacol Ther (2009) 0.75

A rapid test of alloreactivity based on interleukin-2 mRNA expression might identify liver transplant recipients with donor-specific hyporesponsiveness. Transplant Proc (2007) 0.75

Improved results for adult split liver transplantation with extended right lobe grafts: could we enhance its application? Transplant Proc (2009) 0.75

Liver transplantation and mental retardation. Acta Gastroenterol Belg (2002) 0.75

Rectal wall perforation and prostatic necrosis due to malposition of a transurethral bladder catheter. Gastrointest Endosc (1999) 0.75

Cinnarizine-induced cholestasis. J Hepatol (1999) 0.75

Combined prevalence of inherited skeletal disorders in dog breeds in Belgium. Vet Comp Orthop Traumatol (2014) 0.75

The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study. Cancer Biother Radiopharm (2001) 0.75

Improved results for adult split liver transplantation with extended right lobe grafts: could we enhance its application? Transplant Proc (2009) 0.75

Biliary complications of large Echinococcus granulosus cysts: report of 2 cases and review of the literature. Acta Clin Belg (2003) 0.75

Influence of posture on haemodynamics, sodium and hormonal homeostasis in cirrhotic patients with and without ascites. Acta Gastroenterol Belg (2003) 0.75

A new type of partially covered metal stent for treatment of a high esophagotracheal fistula. Endoscopy (1999) 0.75

Review: hepatopulmonary syndrome and portopulmonary hypertension. Acta Gastroenterol Belg (2001) 0.75

Hepatitis C: screening, treatment and prevention practical guidelines. Acta Gastroenterol Belg (2003) 0.75

Are reduced tacrolimus dosages needed in the early postoperative period following living donor liver transplantation in adults? Transplant Proc (2002) 0.75